BioLargo Q1 2023 Earnings Results Webcast and Conference Call on Thursday, May 18, 2023 - 4:30 PM Eastern Time

WESTMINSTER, CA / ACCESSWIRE / May 17, 2023 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Thursday, May 18, 2023, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ended March 31, 2023, discuss recent milestones, and conduct a question-and-answer session.

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.

To participate in the live webcast and teleconference:

Webcast Link:		https://www.webcaster4.com/Webcast/Page/2448/48436
Teleconference Domestic:		888-506-0062
Teleconference International: Participant Access Code:		973-528-0011 918886

To watch or listen to a replay of the teleconference:

Teleconference Replay Expiration:		Wednesday, May 31, 2023
Teleconference Replay Domestic:		877-481-4010
Teleconference Replay International:		919-882-2331
Replay Passcode:		48436

The webcast replay and accompanying presentation materials will be made available for 90 days on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.